Pfizer Inc. (NYSE: PFE) recently released first-quarter 2022 earnings that were better than expected by Wall Street. COVID-19 vaccinations and antiviral medications were two...
Trillium Therapeutics Inc. has inked an acquisition agreement with Pfizer Inc. . As per the acquisition agreement, Trillium will be bought by Pfizer...
Pfizer Inc. has declared the acquisition of Amplyx Pharmaceuticals on Wednesday. Amplyx has gained recognition as a private firm that has pledged to...
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have disclosed Wednesday that their COVID-19 vaccine candidate, BNT162b2, has shown a 95% efficacy rate...
BioNTech SE disclosed Thursday that it is confident to begin the mass production of vaccine before acquiring the regulatory approval. CEO of BioNtech...
